A procedure of filtering the blood outside the body to remove a toxin is called as hemoperfusion. In hemoperfusion. the blood travels from the patient into a machine, gets filtered, and then travels back into the patient likewise other extracorporeal procedures, hemodialysis (HD), hemofiltration (HF), and hemodiafiltration (HDF). Global Hemoperfusion Market was valued at around USD 345 million in 2019 and is expected to reach over USD 900 million in 2027, growing at a CAGR of over 17.5% during the forecast period.
Polystyrene XAD series polymeric adsorbent is a hydrophobic crosslinked polystyrene copolymer resin, supplied as 20-60 mesh size white insoluble beads. The resin is most commonly applied to adsorb soluble organic compounds from aqueous streams and organic solvents in typical cyclic columnar operations. It has unusually good physical durability and is stable at temperatures as high as 200°C. Commercial applications for Polystyrene XAD series resin include removal of antibiotics, organic nitrogen, grease, and various aromatic compounds from aqueous streams. Activated carbon is used to treat poisonings and overdoses following oral ingestion. Tablets or capsules of activated carbon are used in many countries as an over-the-counter drug to treat diarrhea, indigestion, and flatulence.
Download FREE Sample PDF of Global Hemoperfusion Market: https://www.eonmarketresearch.com/sample/76623
Activated carbon adsorption segment dominated the global hemoperfusion market with over 60% share in 2019. In 2019, the Activated Carbon Adsorption sales (K Units) was around 2,900 K Units and it is expected to grow at a CAGR of over 15% from 2020 to 2027.
Global hemoperfusion market is vulnerable from threat of substitute from some of the alternative methods. In acute intoxication, charcoal hemoperfusion is employed for removal of the drug. High-efficiency hemodialysis can be used alternatively with a batch dialysis system (Genius), lowering not only serum levels of carbamazepine but removing a considerable amount of the drug as measured in the dialysate. Hence, high-efficiency hemodialysis is a safe and effective alternative for treating life-threatening carbamazepine intoxication.
On the basis of application, the global hemoperfusion market can be segmented as Liver (Hepatic) Failure, Specific Intoxications, Certain Autoimmune Diseases and Others. Liver (Hepatic) Failure segment dominated the global hemoperfusion market with over 40% share in 2019. It is also expected to be the fastest growing market over the forecast period.
The global hemoperfusion market is dominated by Asia Pacific on the account of strong demand from China. China alone accounted for over one third share of the global hemoperfusion market revenue in 2019. Europe is another significant market for hemoperfusion and closely followed by the North America in 2019. With increasing demand from other Asian countries such as India, South Korea, Southeast Asia and Australia the demand for hemoperfusion is likely grow at a rapid pace in the years to come.
Buy This Premium Report: https://www.eonmarketresearch.com/buy/76623
Customization of the Report: This report can be customized to meet the client’s requirements. Please connect with our sales team (sales@eonmarketresearch.com), who will ensure that you get a report that suits your needs.
The global hemoperfusion market is dominated by few handful companies including Jafron Biomedical, Baxter (Gambro), Biosun Medical, Toray Medical, Kaneka, Cytosorbents and Others. The global hemoperfusion market is highly concentrated with top six companies holding almost 60% share of the total revenue generated in 2019.
Segmentation:
Hemoperfusion Market by Type, 2015 – 2027 Volume (K Units) and Revenue (USD Million)
- Resin Adsorption
- Activated Carbon Adsorption
Hemoperfusion Market by Application, 2015 – 2027 Volume (K Units) and Revenue (USD Million)
- Liver (Hepatic) Failure
- Specific Intoxications
- Certain Autoimmune Diseases
- Others
Hemoperfusion Market by Region, 2015 – 2027 Volume (K Units) and Revenue (USD Million)
North America
- United States
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Russia
- Italy
- Spain
Asia Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Australia
Latin America
- Brazil
- Argentina
- Chile
- Peru
Middle East and Africa
- Egypt
- Saudi Arabia
- South Africa
- Turkey
- Israel
Hemoperfusion Market by Company, 2018 – 2019 Volume (K Units) and Revenue (USD Million)
- Jafron Biomedical
- Baxter (Gambro)
- Biosun Medical
- Toray Medical
- Kaneka
- Cytosorbents
- Others
Do Inquiry Before Purchasing Report Here and Ask For Discount: https://www.eonmarketresearch.com/enquiry/76623
Explore Related Reports:
- Headless Compression Screws Market
- Mammography X-ray Unit Market
- Non-Invasive Glucose Meter Market
- Non-heatable Insufflator Market
- PTCA Catheters Market
- Pollution Control Booms Market
About Us:
Eon Market Research (EMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers.
Contact Us:
Eon Market Research
Phone: +1 703 879 7090
Email: sales@eonmarketresearch.com